Therapy Areas: Inflammatory Diseases
Melodia Therapeutics reports award of US patent covering MLD-151
26 February 2026 - Melodia Therapeutics AG, a clinical-stage biotechnology company based in Switzerland, announced on Wednesday that the United States Patent and Trademark Office (USPTO) has granted a...
GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline
25 February 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) revealed on Wednesday that it has agreed to acquire 35Pharma Inc., a Canada-based clinical-stage biopharmaceutical company, ...
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH
...
Formosa Pharmaceuticals signs licensing deal with Arrotex for APP13007 in Australia and New Zealand
...
Merck and Mayo Clinic launch AI-driven drug discovery collaboration
18 February 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Wednesday announced a research and development agreement with Mayo Clinic to appl...
Palisade Bio makes Clinical Advisory Board appointment
18 February 2026 - Clinical-stage biopharmaceutical company Palisade Bio Inc (Nasdaq:PALI) announced on Tuesday the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board.The company s...